No Data
No Data
Runfeng Co., Ltd. (301035.SZ): Currently, there are sufficient orders and production and operation conditions are good
Gelonghui, April 19 | Runfeng Co., Ltd. (301035.SZ) said on the investor interactive platform that the company currently has sufficient orders and good production and operation conditions. Regarding the company's business situation in the first quarter of 2024, please pay attention to the relevant announcement that the company will issue on April 26.
Heavy warehouse bought back Meituan Kuaishou! Zhong Geng Qiu Dongrong's quarterly report revealed that there were many moves to adjust positions
Early this morning, Qiu Dongrong's products revealed a quarterly report.
Runfeng Co., Ltd. (301035): The industry is declining, and profits are under pressure, and the company's long-term growth is optimistic
Incident: The company released its 2023 performance report on April 1, achieving full-year revenue of 11.485 billion yuan, -20.57% year over year; net profit to mother was 773 million yuan, -45.32% year over year. Achieving revenue in 23Q4 29.
Changes in A-shares | Performance declined, and the volume of Runfeng shares fell by more than 8%
Gelonghui, April 2 | Runfeng Co., Ltd. (301035.SZ) has now fallen by more than 8% to 61.74 yuan. The turnover has increased to 299 million yuan, with a total market value of 17.2 billion yuan. The company announced last night that revenue in 2023 was 11.485 billion yuan, down 20.57% year on year; net profit was 773 million yuan, down 45.32% year on year. Prices of the company's main products have also declined to varying degrees, leading to a significant decline in annual performance.
Express News | Runfeng shares: net profit of 773 million yuan in 2023 decreased by 45.32% year-on-year
Runfeng Co., Ltd. (301035.SZ): The main business scope of the Argentine subsidiary and the Spanish subsidiary is the preparation, processing and sale of formulations
Gelonghui March 8 | Runfeng Co., Ltd. (301035.SZ) said on the investor interactive platform that the main business scope of the Argentine subsidiary and the Spanish subsidiary is the preparation, processing and sale of formulations.
No Data